Qiagen

History

YearDetail
1984 QIAGEN (originally Diagen) was born as a spin-out from the Heinrich-Heine University in Dusseldorf.
1986 It revolutionized molecular biology by introducing the first "Plasmid-Kit".
1996 Introduced the BioRobot 9600, its first bench-top workstation, which automates purification technologies.
1999 Joint venture with Becton, Dickenson and Company is established.
2004 Company QIAamp becomes the world’s first standalone product for sample preparation to receive the CE-mark.
2006 Established Asia regional headquarters in Shanghai.
2007 QIAGEN merged with Digene Corp.
2009 Acquired DxS Ltd.
2010 Launched QIAsymphony RGQ, a highly flexible modular automation platform covering entire laboratory workflows.
2010 QIAGEN acquired a new detection technology for Point of Need.
2011 Expansion in Asia with new subsidiaries in India and Taiwan.
2012 FDA approval for its KRAS test.
2013 Acquired Ingenuity Systems and CLC Bio.
2014 QIAGEN’s technologies play a key role in the fight against the devastating Ebola outbreak in Africa.
2015 Launches the GeneReader NGS System.
2016 Acquires Exiqon A/S.
2018 Partners with NeuMoDx Molecular Inc. 
2022 QIAGEN acquires majority stake in enzymes provider BLIRT S.A.
2023 QIAGEN completes acquisition of Verogen.